TOP STORIES

• ACADEMIA AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
  April 21, 2016

• ACADEMIA 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
  April 20, 2016

• REGULATORY Sales Reps Top Source of Drug Safety Information for Both Clinics and Pharmacies: PMDA Survey
  April 19, 2016

• BUSINESS Wholesalers Say Drug Distributions in Quake-Hit Kumamoto More or Less Stable
  April 19, 2016

• BUSINESS Kaketsuken Halts Operations on April 18-20 after Quake
  April 18, 2016

• REGULATORY Promoting Use of Patient Registries Important in Building Clinical Innovation Network: Health Policy Bureau Chief
  April 18, 2016

• REGULATORY Expedited Review Systems Now in Place in 3 Major Markets, but How Are They Different?
  April 15, 2016

• REGULATORY Indication-Based Front-Loaded Re-Pricing, Coverage Limits Emerge for Pricey Meds: Chuikyo
  April 14, 2016

• REGULATORY Chuikyo OKs Repatha for NHI Price Listing on April 20, Peak Sales Projected at 49 Billion Yen
  April 13, 2016

• BUSINESS Ono Fires Back to 1.75 Trillion Yen Guesstimate, Puts Opdivo Sales at 126 Billion Yen
  April 12, 2016

• ORGANIZATION EFPIA Japan Chief to Call for “Real Dialogue” at Today’s Public-Private Policy Confab
  April 12, 2016

• REGULATORY With Eyes on Pricey Meds, Cost-Shaving Debate Unabated Despite Likely Tax Hike Delay
  April 11, 2016

• BUSINESS Kaketsuken in Talks to Transfer Vaccine Biz to Astellas
  April 8, 2016

• ORGANIZATION Front-Loaded Price Cuts Necessary for Drugs Like Opdivo: JMA’s Nakagawa
  April 7, 2016

• BUSINESS Mylan Japan Labor Union Raps Management over “Effective Dismissal”, No Progress Made in 1st Round of Negotiations
  April 6, 2016

• REGULATORY NCCHD Aims to Build “Million-Person Database” on Pediatric Patients; Could Lead to Improvements in Pharmacotherapy
  April 6, 2016

• REGULATORY MEXT to Set Up “Shared Facilities” for Drug Discovery, Push Open Innovation
  April 5, 2016

• BUSINESS Ex-Pfizer Japan Exec Matsumori to Lead Takeda-Teva JV
  April 4, 2016

• BUSINESS Sakigake: Now and Future (5) - BioCryst’s BCX7353 Would Be Japan’s 1st Drug for Preventing Angioedema Attacks
  April 4, 2016

• BUSINESS Daiichi Sankyo Eyes V-Shaped Recovery from Olmesartan Patent Cliff: 5-Year Plan
  April 1, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• …
• Next ›
• 最終 »